This bill amends Iowa Code to establish definitions and regulations concerning 340B drugs, which are outpatient drugs sold at reduced prices to covered entities under federal law. It introduces new subsections that define a "340B drug," "distributor," and "manufacturer," clarifying the roles of these entities in the pharmaceutical supply chain. Specifically, a 340B drug is defined as one for which a manufacturer has offered a reduced price, while a distributor is identified as any person engaged in the wholesale distribution of prescription drugs, excluding manufacturers.

Additionally, the bill imposes restrictions on manufacturers and distributors, prohibiting them from denying, restricting, or interfering with the acquisition of 340B drugs by covered entities or their delivery to contract pharmacies. This prohibition stands unless such actions are specifically prohibited by the U.S. Department of Health and Human Services. Overall, the bill aims to protect the accessibility of 340B drugs for covered entities and ensure compliance with federal regulations.

Statutes affected:
Introduced: 510D.1, 510D.2